4.6 Article

Extracellular Volume and Global Longitudinal Strain Both Associate With Outcomes But Correlate Minimally

Journal

JACC-CARDIOVASCULAR IMAGING
Volume 13, Issue 11, Pages 2343-2354

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcmg.2020.04.026

Keywords

cardiac magnetic resonance; extracellular volume; global longitudinal strain; interstitium; myocardial fibrosis

Funding

  1. Clinician Scientist Award from the National Institute for Health (NIH) Research [CS-2015-15-003]
  2. American Heart Association Scientist Development grant
  3. Children's Cardiomyopathy Foundation grant
  4. American Heart Association Enduring Hearts grant [14GRNT20380101]
  5. National Center for Advancing Translational Sciences of the NIH [KL2TR000146]
  6. Pittsburgh Foundation [M2009-0068]
  7. American Heart Association Scientist Development grant [09SDG2180083]
  8. T. Franklin Williams Scholarship Award
  9. Atlantic Philanthropies, Inc.
  10. John A. Hartford Foundation
  11. Association of Specialty Professors
  12. American Heart Association
  13. National Center for Research Resources, a component of the NIH [UL1-TR-001857]
  14. NIH Roadmap for Medical Research
  15. Swedish Research Council
  16. Swedish Heart and Lung Foundation
  17. Stockholm County Council
  18. Karolinska Institutet
  19. Roche
  20. Guerbet
  21. Abbott Vascular
  22. Edwards Lifesciences
  23. Medtronic
  24. Boston Scientific
  25. Circle Cardiovascular Imaging
  26. Siemens Healthineers
  27. Medis

Ask authors/readers for more resources

OBJECTIVES This study examined how extracellular volume (ECV) and global longitudinal strain (GLS) relate to each other and to outcomes. BACKGROUND Among myriad changes occurring in diseased myocardium, left ventricular imaging metrics of either the interstitium (e.g., ECV) or contractile function (e.g., GLS) may consistently associate with adverse outcomes yet correlate minimally with each other. This scenario suggests that ECV and GLS potentially represent distinct domains of cardiac vulnerability. METHODS The study included 1,578 patients referred for cardiovascular magnetic resonance (CMR) without amyloidosis, and it quantified how ECV associated with GLS in linear regression models. ECV and GLS were then compared in their associations with incident outcomes (death and hospitalization for heart failure). RESULTS ECV and GLS correlated minimally (R-2 = 0.04). Over a median follow-up of 5.6 years, 339 patients experienced adverse events (149 hospitalizations for heart failure, 253 deaths, and 63 with both). GLS (univariable hazard ratio: 2.07 per 5% increment; 95% CI: 1.86 to 2.29) and ECV (univariable hazard ratio: 1.66 per 4% increment; 95% CI: 1.51 to 1.82) were principal variables associating with outcomes in univariable and multivariable Cox regression models. Similar results were observed in several clinically important subgroups. In the whole cohort, ECV added prognostic value beyond GLS in univariable and multivariable Cox regression models. CONCLUSIONS GLS and ECV may represent principal but distinct domains of cardiac vulnerability, perhaps reflecting their distinct cellular origins. Whether combining ECV and GLS may advance pathophysiological understanding for a given patient, optimize risk stratification, and foster personalized medicine by targeted therapeutics requires further investigation. (C) 2020 the American College of Cardiology Foundation. Published by Elsevier. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available